Worth reading
45Recurring
Scored from 5 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
150
People (capacity)Wording
Conditional
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
IR and investor information for individual investors
Launch date7 July 2026 (planned)
Relationship between the counterparty and the company
Perseus Proteomics Inc.4882
Relationship with the Company
Relationship between the IR seminar host and the company appearing as a speaker
CounterpartyNihon Securities Shimbun
Organizer of an IR seminar for individual investors. Other information, including its location, representative and business activities, is Not disclosed.
Location (as indicated in this announcement)
Tokyo Stock Exchange Building, 8th-floor hall (1-5-8 Nihombashi-Kayabacho, Chuo-ku, Tokyo 103-0025)
Capacity: 150 people
Offering price
Participation fee: Free
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Counterparty | Nihon Securities Shimbun |
| Counterparty overview | Organizer of an IR seminar for individual investors. Other information, including its location, representative and business activities, is Not disclosed. |
| Relationship with the Company | Relationship between the IR seminar host and the company appearing as a speaker |
| Offering price | Participation fee: Free |
| Launch date | 7 July 2026 (planned) |
| Applicable area | IR and investor information for individual investors |
| Location | Tokyo Stock Exchange Building, 8th-floor hall (1-5-8 Nihombashi-Kayabacho, Chuo-ku, Tokyo 103-0025) |
| Location scale | Capacity: 150 people |
Items this document does not state (10)
Names of Products / Services CoveredContract ValueContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To deepen investors’ understanding of our company and provide information for their investment decisions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.